Musk Says ‘Dollar Will Be Worth Nothing…’

Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over $3 Million worth of crypto – and he's not the only one at the top interested in digital assets…

Click here to reserve your free seat at the Crypto Community Summit

Shoshana Shendelman net worth and biography

Shoshana Shendelman Biography and Net Worth

CEO of Applied Therapeutics

Shoshana Shendelman, PhD founded Applied Therapeutics in 2016. She serves as President and Chief Executive Officer as well as Chair of the Board of Directors. Prior to founding Applied Therapeutics, she founded Clearpoint Strategy Group LLC, a boutique life sciences consulting firm, where she served as the Managing Director from July 2012 to December 2016 and served as a Senior Advisor from January 2017 to December 2018. Dr. Shendelman received her Ph.D. in Cellular, Molecular and Biophysical Studies (CMBS) from Columbia University Vagelos College of Physicians and Surgeons.

Dr. Shendelman is a member of the Clinical Advisory Board of Columbia University Medical Center and Columbia University Vagelos College of Physicians & Surgeons, where she serves on the Nominations Committee and the Committee on Innovation and Entrepreneurship.

What is Shoshana Shendelman's net worth?: The estimated net worth of Shoshana Shendelman is at least $43.16 million as of August 14th, 2024. Dr. Shendelman owns 4,690,839 shares of Applied Therapeutics stock worth more than $43,155,719 as of November 14th. This net worth evaluation does not reflect any other investments that Dr. Shendelman may own. Additionally, Dr. Shendelman receives an annual salary of $946,080.00 as CEO at Applied Therapeutics. Learn More about Shoshana Shendelman's net worth.
How old is Shoshana Shendelman?: Dr. Shendelman is currently 45 years old. There are 5 older executives and no younger executives at Applied Therapeutics. Learn More on Shoshana Shendelman's age.
What is Shoshana Shendelman's salary?: As the CEO of Applied Therapeutics, Inc., Dr. Shendelman earns $946,080.00 per year. Learn More on Shoshana Shendelman's salary.
How do I contact Shoshana Shendelman?: The corporate mailing address for Dr. Shendelman and other Applied Therapeutics executives is 340 MADISON AVENUE 19TH FLOOR, NEW YORK NY, 10173. Applied Therapeutics can also be reached via phone at (212) 220-9226 and via email at [email protected]. Learn More on Shoshana Shendelman's contact information.
Has Shoshana Shendelman been buying or selling shares of Applied Therapeutics?: Shoshana Shendelman has not been actively trading shares of Applied Therapeutics in the last ninety days. Most recently, Shoshana Shendelman sold 119,591 shares of the business's stock in a transaction on Wednesday, August 14th. The shares were sold at an average price of $5.93, for a transaction totalling $709,174.63. Following the completion of the sale, the chief executive officer now directly owns 4,690,839 shares of the company's stock, valued at $27,816,675.27. Learn More on Shoshana Shendelman's trading history.
Who are Applied Therapeutics' active insiders?: Applied Therapeutics' insider roster includes Riccardo Perfetti (Insider), Shoshana Shendelman (CEO), and Charles Silberstein (CFO). Learn More on Applied Therapeutics' active insiders.
Are insiders buying or selling shares of Applied Therapeutics?: During the last twelve months, Applied Therapeutics insiders bought shares 1 times. They purchased a total of 30,000 shares worth more than $65,400.00. During the last twelve months, insiders at the sold shares 11 times. They sold a total of 1,134,024 shares worth more than $6,050,151.62. The most recent insider tranaction occured on August, 14th when CEO Shoshana Shendelman sold 119,591 shares worth more than $709,174.63. Insiders at Applied Therapeutics own 8.6% of the company. Learn More about insider trades at Applied Therapeutics.
Information on this page was last updated on 8/14/2024.

Shoshana Shendelman Insider Trading History at Applied Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/14/2024	Sell	119,591	$5.93	$709,174.63	4,690,839
8/12/2024	Sell	300,000	$5.98	$1,794,000.00	5,167,853
6/6/2024	Sell	61,795	$4.32	$266,954.40	3,756,019
3/14/2024	Sell	318,573	$5.39	$1,717,108.47	3,817,814
11/30/2023	Sell	3,968	$1.97	$7,816.96	2,596,387
9/27/2023	Sell	115,632	$2.70	$312,206.40	2,600,355
1/11/2023	Sell	15,870	$0.91	$14,441.70	751,625
10/14/2022	Buy	50,000	$0.65	$32,500.00	767,495
10/12/2022	Buy	38,153	$0.52	$19,839.56	644,239
9/13/2021	Buy	701	$14.69	$10,297.69	354,986
7/21/2020	Sell	15,000	$27.06	$405,900.00	569,285
7/9/2020	Sell	15,000	$31.10	$466,500.00	569,285
7/7/2020	Sell	15,000	$32.17	$482,550.00	569,285
5/28/2020	Sell	125,000	$42.70	$5,337,500.00	3,014,005
5/16/2019	Buy	125,000	$10.00	$1,250,000.00

Shoshana Shendelman Buying and Selling Activity at Applied Therapeutics

Applied Therapeutics Company Overview

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Today's Range

Now: $9.01

$8.71

$9.29

50 Day Range

MA: $8.06

$4.65

$10.24

2 Week Range

Now: $9.01

$1.79

$10.62

Volume

2,460,114 shs

Average Volume

1,836,921 shs

Market Capitalization

$1.05 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.01

Musk Says ‘Dollar Will Be Worth Nothing…’

From Crypto 101 Media | Ad

Click here to reserve your free seat at the Crypto Community Summit

Shoshana Shendelman Biography and Net Worth

What is Shoshana Shendelman's net worth?

How old is Shoshana Shendelman?

What is Shoshana Shendelman's salary?

How do I contact Shoshana Shendelman?

Has Shoshana Shendelman been buying or selling shares of Applied Therapeutics?

Who are Applied Therapeutics' active insiders?

Are insiders buying or selling shares of Applied Therapeutics?